Viewing Study NCT01067833


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2025-12-31 @ 3:06 AM
Study NCT ID: NCT01067833
Status: TERMINATED
Last Update Posted: 2011-05-16
First Post: 2010-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of Oral K201 for Prevention of AF Recurrence
Sponsor: Sequel Pharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module